๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Third-line therapy for advanced non-small-cell lung cancer patients: feasible drugs for feasible patients

โœ Scribed by Zhengbo Song; Yongfeng Yu; Zhiwei Chen; Shun Lu

Publisher
Springer US
Year
2010
Tongue
English
Weight
387 KB
Volume
28
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Recent advances in etoposide therapy for
Recent advances in etoposide therapy for non-small cell lung cancer
โœ Philip Bonomi ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 504 KB

Non-small cell lung cancer (NSCLC) continues to be a major health problem in the US. In 1990, approximately 120,000 new cases will be diagnosed, and the majority of these patients will have either unresectable disease or resected disease that has a relatively low chance of being cured. A variety of